PINK COPYRIGHT - AN OVERVIEW

Pinpointing that 2C-B had a higher opportunity for abuse and no significant or recognized medical use, the DEA classified the drug for a Agenda I controlled compound in 1995, indicating that it is now unlawful to have in the United States.This is why we choose to think about pink copyright like a kind of drug-taking conduct rather then for a drug b